233 related articles for article (PubMed ID: 36566436)
21. Systemic optimization and structural evaluation of quinoline derivatives as transthyretin amyloidogenesis inhibitors.
Kim B; Park H; Lee SK; Park SJ; Koo TS; Kang NS; Hong KB; Choi S
Eur J Med Chem; 2016 Nov; 123():777-787. PubMed ID: 27541261
[TBL] [Abstract][Full Text] [Related]
22. Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade.
Bulawa CE; Connelly S; Devit M; Wang L; Weigel C; Fleming JA; Packman J; Powers ET; Wiseman RL; Foss TR; Wilson IA; Kelly JW; Labaudinière R
Proc Natl Acad Sci U S A; 2012 Jun; 109(24):9629-34. PubMed ID: 22645360
[TBL] [Abstract][Full Text] [Related]
23. Iodine atoms: a new molecular feature for the design of potent transthyretin fibrillogenesis inhibitors.
Mairal T; Nieto J; Pinto M; Almeida MR; Gales L; Ballesteros A; Barluenga J; Pérez JJ; Vázquez JT; Centeno NB; Saraiva MJ; Damas AM; Planas A; Arsequell G; Valencia G
PLoS One; 2009; 4(1):e4124. PubMed ID: 19125186
[TBL] [Abstract][Full Text] [Related]
24. Per- and Polyfluoroalkyl Substances Are Positively Associated with Thyroid Hormones in an Arctic Seabird.
Ask AV; Jenssen BM; Tartu S; Angelier F; Chastel O; Gabrielsen GW
Environ Toxicol Chem; 2021 Mar; 40(3):820-831. PubMed ID: 33369782
[TBL] [Abstract][Full Text] [Related]
25. Semi-quantitative models for identifying potent and selective transthyretin amyloidogenesis inhibitors.
Connelly S; Mortenson DE; Choi S; Wilson IA; Powers ET; Kelly JW; Johnson SM
Bioorg Med Chem Lett; 2017 Aug; 27(15):3441-3449. PubMed ID: 28625364
[TBL] [Abstract][Full Text] [Related]
26. Diflunisal analogues stabilize the native state of transthyretin. Potent inhibition of amyloidogenesis.
Adamski-Werner SL; Palaninathan SK; Sacchettini JC; Kelly JW
J Med Chem; 2004 Jan; 47(2):355-74. PubMed ID: 14711308
[TBL] [Abstract][Full Text] [Related]
27. Characterization of little skate (Leucoraja erinacea) recombinant transthyretin: Zinc-dependent 3,3',5-triiodo-l-thyronine binding.
Suzuki S; Kasai K; Yamauchi K
Gen Comp Endocrinol; 2015; 217-218():43-53. PubMed ID: 25863347
[TBL] [Abstract][Full Text] [Related]
28. The discovery and development of transthyretin amyloidogenesis inhibitors: what are the lessons?
Zhong B; Huang X; Zheng Y; Guo X; Wu L
Future Med Chem; 2021 Dec; 13(23):2083-2105. PubMed ID: 34633220
[TBL] [Abstract][Full Text] [Related]
29. Crystallographic study of novel transthyretin ligands exhibiting negative-cooperativity between two thyroxine binding sites.
Tomar D; Khan T; Singh RR; Mishra S; Gupta S; Surolia A; Salunke DM
PLoS One; 2012; 7(9):e43522. PubMed ID: 22973437
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of transthyretin amyloid fibril formation by 2,4-dinitrophenol through tetramer stabilization.
Raghu P; Reddy GB; Sivakumar B
Arch Biochem Biophys; 2002 Apr; 400(1):43-7. PubMed ID: 11913969
[TBL] [Abstract][Full Text] [Related]
31. Effects on thyroid hormone metabolism and depletion of lung vitamin A in rats by airborne particulate matter.
Heussen GA; Schefferlie GJ; Talsma MJ; van Til H; Dohmen MJ; Brouwer A; Alink GM
J Toxicol Environ Health; 1993 Apr; 38(4):419-34. PubMed ID: 8478982
[TBL] [Abstract][Full Text] [Related]
32. Review on the Structures and Activities of Transthyretin Amyloidogenesis Inhibitors.
Guo X; Liu Z; Zheng Y; Li Y; Li L; Liu H; Chen Z; Wu L
Drug Des Devel Ther; 2020; 14():1057-1081. PubMed ID: 32210536
[TBL] [Abstract][Full Text] [Related]
33. The interaction of zinc with the multi-functional plasma thyroid hormone distributor protein, transthyretin: evolutionary and cross-species comparative aspects.
Yamauchi K
Biometals; 2021 Jun; 34(3):423-437. PubMed ID: 33686575
[TBL] [Abstract][Full Text] [Related]
34. Bisaryloxime ethers as potent inhibitors of transthyretin amyloid fibril formation.
Johnson SM; Petrassi HM; Palaninathan SK; Mohamedmohaideen NN; Purkey HE; Nichols C; Chiang KP; Walkup T; Sacchettini JC; Sharpless KB; Kelly JW
J Med Chem; 2005 Mar; 48(5):1576-87. PubMed ID: 15743199
[TBL] [Abstract][Full Text] [Related]
35. Binding of Per- and Polyfluoroalkyl Substances to the Human Pregnane X Receptor.
Lai TT; Eken Y; Wilson AK
Environ Sci Technol; 2020 Dec; 54(24):15986-15995. PubMed ID: 33228354
[TBL] [Abstract][Full Text] [Related]
36. Insight into the binding model of per- and polyfluoroalkyl substances to proteins and membranes.
Zhao L; Teng M; Zhao X; Li Y; Sun J; Zhao W; Ruan Y; Leung KMY; Wu F
Environ Int; 2023 May; 175():107951. PubMed ID: 37126916
[TBL] [Abstract][Full Text] [Related]
37. Transthyretin-Binding Activity of Complex Mixtures Representing the Composition of Thyroid-Hormone Disrupting Contaminants in House Dust and Human Serum.
Hamers T; Kortenkamp A; Scholze M; Molenaar D; Cenijn PH; Weiss JM
Environ Health Perspect; 2020 Jan; 128(1):17015. PubMed ID: 32003587
[TBL] [Abstract][Full Text] [Related]
38. Natural polyphenols inhibit different steps of the process of transthyretin (TTR) amyloid fibril formation.
Ferreira N; Saraiva MJ; Almeida MR
FEBS Lett; 2011 Aug; 585(15):2424-30. PubMed ID: 21740906
[TBL] [Abstract][Full Text] [Related]
39. Hormone delivery systems to the brain-transthyretin.
Schreiber G; Southwell BR; Richardson SJ
Exp Clin Endocrinol Diabetes; 1995; 103(2):75-80. PubMed ID: 7553078
[TBL] [Abstract][Full Text] [Related]
40. Hormone affinity and fibril formation of piscine transthyretin: the role of the N-terminal.
Morgado I; Melo EP; Lundberg E; Estrela NL; Sauer-Eriksson AE; Power DM
Mol Cell Endocrinol; 2008 Nov; 295(1-2):48-58. PubMed ID: 18620020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
